JGC
ZYME icon

J. Goldman & Co’s Zymeworks ZYME Stock Holding History

J. Goldman & Co’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-119,956
Closed -$1.51M – 661
2024
Q3 		$1.51M Sell
119,956
-54,433
-31% -$593K 0.04% 255
2024
Q2 		$1.48M Buy
+174,389
New +$1.55M 0.04% 272
2022
Q4 		– Sell
-291,000
Closed -$1.79M – 510
2022
Q3 		$1.79M Buy
291,000
+258,298
+790% +$1.56M 0.09% 216
2022
Q2 		$173K Buy
+32,702
New +$198K 0.01% 312
2021
Q4 		– Sell
-49,992
Closed -$1.45M – 463
2021
Q3 		$1.45M Sell
49,992
-17,970
-26% -$597K 0.07% 221
2021
Q2 		$2.36M Buy
+67,962
New +$2.16M 0.09% 212
2018
Q4 		– Sell
-50,283
Closed -$789K – 330
2018
Q3 		$789K Sell
50,283
-104,967
-68% -$1.5M 0.06% 199
2018
Q2 		$2.29M Buy
+155,250
New +$2.4M 0.12% 200

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

J. Goldman & Co's ZYME Position: Q4 2024 in Review

J. Goldman & Co sold out of Zymeworks (ZYME) in Q4 2024, closing a stake of 119,956 shares — an estimated $1.51M sold.

J. Goldman & Co first reported a position in ZYME in Q2 2018 and held it in 8 quarters. The position peaked at $2.36M in Q2 2021. 172 funds tracked by Wall St. Rank hold ZYME as of Q4 2024.

  • J. Goldman & Co reported no remaining Zymeworks position as of Q4 2024 after selling out during the quarter.
  • J. Goldman & Co sold 119,956 Zymeworks shares in Q4 2024, an estimated $1.51M.
  • J. Goldman & Co first reported a position in Zymeworks in Q2 2018 and held it in 8 quarters.
  • J. Goldman & Co's Zymeworks position peaked at $2.36M in Q2 2021.
  • 172 funds tracked by Wall St. Rank held Zymeworks as of Q4 2024.

Based on J. Goldman & Co's 13F filing for Q4 2024, filed 14 Feb 2025.